Clinical Trials Directory

Trials / Completed

CompletedNCT02992639

Weight Loss Effect on Circulating Liver Enzymes

Weight Loss Effect on Circulating Levels of Liver Enzymes in Overweight Subjects With High Visceral Fat Area: 12-week Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Accepted

Summary

To investigate weight loss effect with mild calorie restriction on circulating levels of liver enzymes in nondiabetic and overweight subjects with high visceral fat area \[visceral fat area (VFA) at L4 ≥ 100 cm²\].

Detailed description

A 12-week randomized, placebo-controlled study was conducted on 80 nondiabetic and overweight subjects with high VFA. The participants divided into two groups: 12-week mild calorie restriction (a 300 kcal/day intake reduction, n=40) or no treatment (control, n=40). The randomization was according to computer-generated block randomization (placebo:test = 1:1). Before and after intervention period, venous blood samples were obtained from the subjects, and biochemical parameters including circulating liver enzymes were measured.

Conditions

Interventions

TypeNameDescription
BEHAVIORALControl groupThe participants who included in control group did not receive any treatment.
BEHAVIORALWeight loss groupThe participants who included in weight loss group followed a 12-week weight loss program consisting of a 300 kcal/day reduction of thier usual caloric intakes

Timeline

Start date
2015-06-01
Primary completion
2016-10-01
Completion
2016-10-01
First posted
2016-12-14
Last updated
2017-02-15

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02992639. Inclusion in this directory is not an endorsement.